ALD:ASXAmpol Limited Analysis
Data as of 2026-05-27 - not real-time
A$33.68
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Ampol (ALD) is trading at AUD 33.68, just above the computed support of AUD 33.08 and below its 20‑day SMA of AUD 34.72, indicating a price floor but limited upside to the resistance near AUD 36.45. The MACD histogram is negative and the signal line is bearish, while RSI sits at 45, suggesting neutral momentum and a potential short‑term pullback despite a bullish trend direction flag. Recent material news shows the company advancing its EG Australia acquisition and submitting a 41‑site divestment remedy, which has injected fresh optimism and helped push the shares higher. Fundamentally, the stock appears stretched – a trailing P/E of 99 versus an industry average of 20.7, a DCF‑derived fair value of only AUD 12.99, and a payout ratio above 130% raise serious dividend sustainability concerns. The balance sheet is leveraged (debt‑to‑equity 122%) and free cash flow is negative, while operating margins sit under 3%, limiting organic growth. Nevertheless, the forward P/E of 14.4 hints at earnings improvement once the acquisition synergies materialise, and the dividend yield of 3.56% remains attractive if the payout can be re‑scaled. Overall, the stock sits at the intersection of a short‑term technical support level, a medium‑term acquisition catalyst, and a long‑term valuation mismatch that favours caution.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical support with limited downside
- Positive acquisition and divestment news driving sentiment
- Attractive dividend yield despite sustainability concerns
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward P/E suggests earnings upside from acquisition integration
- High leverage and negative free cash flow limit margin improvement
- Volatile commodity environment adds earnings uncertainty
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- DCF fair value far below current market price
- Unsustainable dividend payout and weak profit margins
- Elevated debt levels increase financial risk over time
Key Metrics & Analysis
Financial Health
Revenue Growth-3.40%
Profit Margin0.26%
P/E Ratio99.1
ROE3.89%
ROA2.83%
Debt/Equity122.04
P/B Ratio2.6
Op. Cash FlowA$794.8M
Free Cash FlowA$-176550000
Industry P/E20.7
Technical Analysis
TrendBullish
RSI45.0
SupportA$33.08
ResistanceA$36.45
MA 20A$34.72
MA 50A$33.80
MA 200A$31.15
MACDBearish
VolumeStable
Fear & Greed Index91.32
Valuation
Fair ValueA$12.99
Target PriceA$36.46
Upside/Downside8.24%
GradeOvervalued
TypeBlend
Dividend Yield3.56%
Risk Assessment
Beta-0.05
Volatility27.77%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.